JNBA Financial Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

JNBA Financial Advisors’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3	Closed	-$56	–	759
2023 Q3	$56	Buy	+3	New	+$34	﹤0.01%	738
2018 Q4	–	Sell	-140	Closed	-$18K	–	742
2018 Q3	$18K	Buy	+140	New	+$14.8K	0.01%	327

JNBA Financial Advisors's ICPT Position: Q4 2023 in Review

JNBA Financial Advisors sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 3 shares — an estimated $56 sold.

JNBA Financial Advisors first reported a position in ICPT in Q3 2018 and held it in 2 quarters. The position peaked at $18K in Q3 2018. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

JNBA Financial Advisors reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
JNBA Financial Advisors sold 3 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $56.
JNBA Financial Advisors first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2018 and held it in 2 quarters.
JNBA Financial Advisors's Intercept Pharmaceuticals, Inc. position peaked at $18K in Q3 2018.
0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on JNBA Financial Advisors's 13F filing for Q4 2023, filed 8 Feb 2024.